Sponsor or institution
Clinical trials and research at Dare Bioscience, INC.
As of November 12, 2026, Find a Trial lists 4 NIH-funded research projects at this institution, with $3.9 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4NIH research projects
NIH-funded research (4)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Targeting FKBP51 to Prevent Stress-Related Preterm Birth
A new drug approach aims to block a stress-related protein (FKBP51) to help prevent preterm birth in pregnant people.
-
First-in-class agent to clear high-risk HPV in women
A new vaginal insert combining two antiviral drugs aims to clear high-risk HPV infections in women who have persistent infections.
-
A new vaginal treatment for high-risk HPV infections
This study is testing a new vaginal insert called DARE-HPV that aims to help women clear stubborn high-risk HPV infections, which can lead to cervical cancer, using a combination of two medications that support healthy cell growth.
-
A new device that releases progesterone to help prevent early births in at-risk women
This study is testing a new vaginal ring that slowly releases natural progesterone to help prevent early births in women who are at risk, making it easier for them to get the treatment they need.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.